Skip to main content
. 2020 Apr 29;10(4):79–89. doi: 10.5500/wjt.v10.i4.79

Table 4.

Other clinical findings

Control group Study group P value
Duration of procedure 44.0 ± 11.0 44.9 ± 9.8 0.783
Location of fistula creation -
Dominant 1 (5.0%) 0 (0.0%)
Non-dominant 19 (95.0%) 21 (100.0%)
Fistula location
Brachiocephalic 12 (60.0%) 13 (61.9%) > 0.999
Snuff-box 4 (20.0%) 4 (19.0%) > 0.999
Radiocephalic 3 (15.0%) 4 (19.0%) > 0.999
Brachiobasilic 1 (5.0%) 0 (0.0%) -
Incision length 3.0 (2.0-5.0) 3.0 (2.0-5.0) 0.979
Estimated blood loss 42.5 (20.0-120.0) 50.0 (10.0-120.0) 0.530
VAS 4.5 (2.0-10.0) 2.0 (1.0-8.0) < 0.001
Willingness to repeat the procedure 3.0 (1.0-9.0) 8.0 (5.0-10.0) < 0.001
Demand of analgesic 9 (45.0%) 3 (14.3%) 0.069
Amount of local analgesic 22.5 (15.0-38.0) 20.0 (15.0-40.0) 0.607
Anticoagulant 14 (70.0%) 12 (57.1%) 0.596
Beta blocker 2 (10.0%) 4 (19.0%) 0.663
Antihypertensive 10 (50.0%) 12 (57.1%) 0.885

VAS: Visual analog scale.